Core Viewpoint - The event "2025 Cross-Border Cooperation in Life and Health Industry: A Dialogue with the World's Top 500" highlights China's commitment to fostering innovation and collaboration in the life and health sector, particularly in the Guangdong-Hong Kong-Macao Greater Bay Area, which is seen as a core cluster for industry development [1][2]. Group 1: Government Initiatives - The Investment Promotion Bureau emphasizes that China's economic stability and growth momentum remain unchanged, with a focus on attracting foreign investment through open and cooperative policies [1]. - Specific measures have been introduced to encourage research and development, expedite review and approval processes, and provide support for essential resources in the life and health industry [1]. - The Investment Promotion Bureau will continue to monitor opportunities in the Greater Bay Area's life and health industry and facilitate practical cooperation between enterprises [1]. Group 2: Regional Development - The Greater Bay Area is positioned as a key cluster for the life and health industry, benefiting from a complete industrial ecosystem, open policy framework, active capital markets, and extensive application scenarios [1]. - The region is welcoming global life and health enterprises to share in the new development opportunities presented by the Greater Bay Area [1]. Group 3: Industry Participation - Representatives from over 100 companies and institutions, including major players like Bayer, Pfizer, and GE Healthcare, participated in discussions about business operations and investment opportunities in China [2]. - The Zhuhai municipal departments addressed concerns related to the review and approval of innovative drugs, cross-border research and development, and the facilitation of cross-border financing [2].

Core Viewpoint - The event held in Yinchuan showcased approximately 2,500 technological achievements selected from various universities, research institutions, medical organizations, and enterprises across the country, aiming to enhance the health supply quality and efficiency in Ningxia [1][2]. Group 1: Event Overview - The event was organized by the Ningxia Hui Autonomous Region Health Commission and the Ningxia Hui Autonomous Region Science and Technology Department [1]. - Significant collaborations were established between local innovative entities and institutions such as Zhejiang University and Shanghai University of Traditional Chinese Medicine [1]. - Twelve major technology cooperation projects were signed on-site, including innovations in digital therapy for chronic respiratory diseases and rapid diagnostic technologies for blood infection pathogens [1]. Group 2: Strategic Initiatives - The Ningxia Science and Technology Department has established cooperative relationships with 22 provinces and cities, as well as 67 pharmaceutical universities, research institutions, and medical organizations [1]. - The initiative aims to bridge the gap in medical resources and enhance the quality of health supply through comprehensive innovation [1]. - Future efforts will focus on transforming cooperation intentions into tangible outcomes to support the high-quality development of the life and health industry in Ningxia [2].